Global Pomalidomide Market is segmented, by Dosage Forms & Strengths into 1mg, 2mg, 3mg, and 4mg. Pomalidomide is a small molecule analog of thalidomide under growth with Celgene company for the oral treatment of hematological and connective tissue diseases.
Comments
Content
Global Pomalidomide Market is segmented, by Dosage Forms & Strengths into 1mg, 2mg, 3mg, and 4mg. Pomalidomide is a small molecule analog of thalidomide under growth with Celgene company for the oral treatment of hematological and connective tissue diseases.